DuPont Industrial Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- DuPont Industrial Biosciences's estimated annual revenue is currently $122.8M per year.
- DuPont Industrial Biosciences's estimated revenue per employee is $262,500
Employee Data
- DuPont Industrial Biosciences has 468 Employees.
DuPont Industrial Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $150.2M | 563 | 12% | N/A | N/A |
#2 | $7.3M | 46 | 7% | $84.4M | N/A |
#3 | $110.5M | 421 | 18% | N/A | N/A |
#4 | $41.6M | 180 | 7% | N/A | N/A |
#5 | $27.3M | 130 | 23% | N/A | N/A |
#6 | $4M | 27 | -57% | N/A | N/A |
#7 | $2.3M | 0 | N/A | $381.6M | N/A |
#8 | $64.9M | 281 | 4% | N/A | N/A |
#9 | $22.5M | 107 | 19% | N/A | N/A |
#10 | $20.4M | 97 | 5% | $47.9M | N/A |
What Is DuPont Industrial Biosciences?
DuPont Industrial Biosciences delivers biobased solutions to meet the needs of a growing population, while making industrial processes more sustainable.
keywords:N/A
N/A
Total Funding
468
Number of Employees
$122.8M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
DuPont Industrial Biosciences News
2022-04-20 - Defoliant Market Strategic Assessment & SWOT Analysis 2021 ...
... Bayer AG, Novozymes, Syngenta, Valent BioSciences LLC, Dow., DuPont ... It assists in obtaining an extreme sense of evolving industry...
2022-04-17 - Enzymes Market Size, Scope And Outlook | DuPont, BASF ...
DuPont, BASF, DSM, Associated British Foods, Novozymes, Kerry Group, Advanced Enzymes, Dyadic International, Augene Biosciences, and Chr. Hansen.
2022-04-17 - Read Statistics 2022 Report on Global Food Enzymes Market
Introduction, Overview, and in-depth industry analysis are all included in the ... In 2021, DuPont Nutrition & Biosciences (DuPont) released...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $105.3M | 468 | 49% | $2M |
#2 | $117.5M | 468 | N/A | N/A |
#3 | $193.1M | 468 | 6% | N/A |
#4 | $158M | 468 | 11% | N/A |
#5 | $122.9M | 468 | 7% | N/A |